<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="letter">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">J Postgrad Med</journal-id>
      <journal-id journal-id-type="iso-abbrev">J Postgrad Med</journal-id>
      <journal-id journal-id-type="publisher-id">JPGM</journal-id>
      <journal-title-group>
        <journal-title>Journal of Postgraduate Medicine</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0022-3859</issn>
      <issn pub-type="epub">0972-2823</issn>
      <publisher>
        <publisher-name>Medknow Publications &amp; Media Pvt Ltd</publisher-name>
        <publisher-loc>India</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">25766355</article-id>
      <article-id pub-id-type="pmc">4943422</article-id>
      <article-id pub-id-type="publisher-id">JPGM-61-140</article-id>
      <article-id pub-id-type="doi">10.4103/0022-3859.153110</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Letters</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>The peculiar case of a blue man</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Biswas</surname>
            <given-names>A</given-names>
          </name>
          <xref ref-type="aff" rid="aff1"/>
          <xref ref-type="corresp" rid="cor1"/>
        </contrib>
      </contrib-group>
      <aff id="aff1">Department of Medicine, University of Pittsburgh Medical Center East, Monroeville, Pennsylvania, United States of America</aff>
      <author-notes>
        <corresp id="cor1"><bold>Address for correspondence:</bold> Dr. Abhishek Biswas, E-mail: <email xlink:href="abiswas@ufl.edu">abiswas@ufl.edu</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <season>Apr-Jun</season>
        <year>2015</year>
      </pub-date>
      <volume>61</volume>
      <issue>2</issue>
      <fpage>140</fpage>
      <lpage>141</lpage>
      <permissions>
        <copyright-statement>Copyright: &#xA9; 2015 Journal of Postgraduate Medicine</copyright-statement>
        <copyright-year>2015</copyright-year>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-sa/3.0">
          <license-p>This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.</license-p>
        </license>
      </permissions>
    </article-meta>
  </front>
  <body>
    <p>Sir,</p>
    <p>A 53-year-old male patient was admitted to our hospital with alcoholic hepatitis and hepatic encephalopathy. He was mildly confused at the time of admission which precluded a detailed history including medication history. Physical examination revealed a prominent bluish discoloration of his skin with icteric conjunctiva and generalized edema. Pulse and blood pressure were normal and pulse oximetry saturations ranged between 91% and 94% at room temperature. The bluish discoloration was noted over the face, trunk and legs [Figures <xref ref-type="fig" rid="F1">1</xref> and <xref ref-type="fig" rid="F2">2</xref>]. Differential diagnosis considered are enumerated in <xref ref-type="table" rid="T1">Table 1</xref>. Multiple scarred bluish pigmented acneiform lesions were also noted over the back. There was ascites without organomegaly. A blood gas analysis revealed normal oxygen and CO2 levels and methemoglobin content was within normal limits. A detailed review several days later revealed that the patient was taking 100 mg of Minocycline daily for last 3 years for treatment of acne (cumulative dose of approximately 11 grams). His laboratory investigations revealed a normal ceruloplasmin and morning cortisol levels. A liver biopsy excluded hemosiderosis.</p>
    <fig id="F1" position="float">
      <label>Figure 1</label>
      <caption>
        <p>Photograph of the patients face shows a diffuse fixed bluish discoloration over his face, similar discoloration was noted over the entire trunk</p>
      </caption>
      <graphic xlink:href="JPGM-61-140-g001"/>
    </fig>
    <fig id="F2" position="float">
      <label>Figure 2</label>
      <caption>
        <p>A spotted as well as confluent pattern of hyperpigmentation was most prominent over anterior aspect of both legs</p>
      </caption>
      <graphic xlink:href="JPGM-61-140-g002"/>
    </fig>
    <table-wrap id="T1" position="float">
      <label>Table 1</label>
      <caption>
        <p>Enumerating the differential diagnosis of bluish hyperpigmentation of the skin after exclusion of cyanotic causes</p>
      </caption>
      <table frame="hsides" rules="groups">
        <tbody>
          <tr>
            <td align="left" rowspan="1" colspan="1">Drug-induced hyperpigmentation</td>
            <td align="left" rowspan="1" colspan="1">Chloroquine, amiodarone, doxorubicin, phenothiazine, minocycline, bismuth and hydroxychloroquine<sup>[<xref rid="ref1" ref-type="bibr">1</xref>]</sup></td>
          </tr>
          <tr>
            <td align="left" rowspan="1" colspan="1">Drug-induced methemoglobinemia</td>
            <td align="left" rowspan="1" colspan="1">Dapsone, aniline dyes, lidocaine and benzocaine</td>
          </tr>
          <tr>
            <td align="left" rowspan="1" colspan="1">Argyria and chrysiasis</td>
            <td align="left" rowspan="1" colspan="1">Gold and silver toxicity respectively<sup>[<xref rid="ref1" ref-type="bibr">1</xref>]</sup></td>
          </tr>
          <tr>
            <td align="left" rowspan="1" colspan="1">Metabolic diseases</td>
            <td align="left" rowspan="1" colspan="1">Hemochromatosis, alkaptonuria, Addison's disease, and Wilson's disease</td>
          </tr>
        </tbody>
      </table>
    </table-wrap>
    <p>A skin biopsy revealed dark, nearly black pigment deposition within macrophages. This again correlated with minocycline-induced hyperpigmentation. Minocycline is a synthetic tetracycline with a prolonged half-life of (<italic>t</italic>1/2 of 15.5 hours). It is used for the treatment of moderate to severe acne and as a disease modifying agent for treatment of rheumatoid arthritis and osteoarthritis. Long-term use of minocycline in cumulative doses of greater than 100 grams have been known to be associated with pigmentation, although smaller doses can also result in mucosal pigmentation.[<xref rid="ref2" ref-type="bibr">2</xref>] The prevalence of hyperpigmentation after treatment for 10.5 months among 700 patients was 0.4% at a dose of 100 mg/day and 4% at 200 mg/day.[<xref rid="ref3" ref-type="bibr">3</xref>] Another study revealed that 2.4% to 14.8% of patients taking minocycline chronically for acne or rosacea developed hyperpigmentation.[<xref rid="ref4" ref-type="bibr">4</xref>] This hyperpigmentation is of three types. Our patient had type II lesions on the legs which are well-circumscribed lesions characteristically seen on healthy skin [<xref ref-type="fig" rid="F2">Figure 2</xref>]. Type III is a diffuse hyperpigmentation over sun-exposed areas as seen over the face and these are less likely to respond to laser therapy [<xref ref-type="fig" rid="F1">Figure 1</xref>].[<xref rid="ref5" ref-type="bibr">5</xref>] Lesions on the back might infrequently appear that resemble Type I lesions developing within acne scars.[<xref rid="ref4" ref-type="bibr">4</xref>] Type I lesions are bluish-black macules that develop over acneiform lesions on the face.[<xref rid="ref6" ref-type="bibr">6</xref>] Although unclear, possible mechanisms for this pigmentation include siderosis, deposition of insoluble complexes of minocycline or its derivatives chelated to iron, melanin or calcium.[<xref rid="ref4" ref-type="bibr">4</xref><xref rid="ref6" ref-type="bibr">6</xref>] The patient was offered Alexandrite&#x2122; laser therapy but refused treatment because of his chronic ill health and decompensated alcoholic liver disease. Alexandrite lasers (755-nm), Nd:YAG (532-/1064-nm) and Ruby(694-nm) lasers have been reported to help resolution of all types ofminocycline-induced hyperpigmentation. It is hypothesized that the laser fragments the intracellular and extracellular pigments and aids in their drainage through the lymphatics.[<xref rid="ref7" ref-type="bibr">7</xref>] Laser adverse effects are limited to mild desquamation and transient purpura without significant lasting hypopigmentation or scarring.[<xref rid="ref7" ref-type="bibr">7</xref><xref rid="ref8" ref-type="bibr">8</xref>] It is important to periodically check for pigmentation among patients on minocycline to prevent cosmetic disfigurement. Estrogen preparations, phenothiazines and amitriptyline that have the propensity to potentiate pigmentation and thus co-therapy is best avoided.[<xref rid="ref9" ref-type="bibr">9</xref>] Sunlight has also been known to aggravate hyperpigmentation and sunscreens with high SPF are recommended.[<xref rid="ref10" ref-type="bibr">10</xref>]</p>
    <sec disp-level="2" id="sec2-1">
      <title>Declaration of Patient Consent</title>
      <p>The authors certify that they have obtained all appropriate patient consent forms. In the form the patient(s) has/have given his/her/their consent for his/her/their images and other clinical information to be reported in the journal. The patients understand that their names and initials will not be published and due efforts will be made to conceal their identity, but anonymity cannot be guaranteed.</p>
    </sec>
  </body>
  <back>
    <ref-list>
      <ref id="ref1">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zuckerman</surname>
              <given-names>MD</given-names>
            </name>
            <name>
              <surname>Boyle</surname>
              <given-names>KL</given-names>
            </name>
            <name>
              <surname>Rosenbaum</surname>
              <given-names>CD</given-names>
            </name>
          </person-group>
          <article-title>Minocycline toxicity: Case files of the University of Massachusetts medical toxicology fellowship</article-title>
          <source>J Med Toxicol</source>
          <year>2012</year>
          <volume>8</volume>
          <fpage>304</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="pmid">22777680</pub-id>
        </element-citation>
      </ref>
      <ref id="ref2">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Roberts</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Capell</surname>
              <given-names>HA</given-names>
            </name>
          </person-group>
          <article-title>The frequency and distribution of minocycline induced hyperpigmentation in a rheumatoid arthritis population</article-title>
          <source>J Rheumatol</source>
          <year>2006</year>
          <volume>33</volume>
          <fpage>1254</fpage>
          <lpage>7</lpage>
          <pub-id pub-id-type="pmid">16758512</pub-id>
        </element-citation>
      </ref>
      <ref id="ref3">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kalia</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Adams</surname>
              <given-names>SP</given-names>
            </name>
          </person-group>
          <article-title>Dermacase. Minocycline-induced pigmentation</article-title>
          <source>Can FamPhysician</source>
          <year>2006</year>
          <volume>52</volume>
          <fpage>595</fpage>
          <lpage>6</lpage>
        </element-citation>
      </ref>
      <ref id="ref4">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Goulden</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Glass</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Cunliffe</surname>
              <given-names>WJ</given-names>
            </name>
          </person-group>
          <article-title>Safety of long-term high-dose minocycline in the treatment of acne</article-title>
          <source>Br J Dermatol</source>
          <year>1996</year>
          <volume>134</volume>
          <fpage>693</fpage>
          <lpage>5</lpage>
          <pub-id pub-id-type="pmid">8733373</pub-id>
        </element-citation>
      </ref>
      <ref id="ref5">
        <label>5</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>James</surname>
              <given-names>WD</given-names>
            </name>
            <name>
              <surname>Elston</surname>
              <given-names>DM</given-names>
            </name>
            <name>
              <surname>Berger</surname>
              <given-names>TG</given-names>
            </name>
          </person-group>
          <article-title>Andrews&#x2019; Diseases of the Skin: Clinical Dermatology</article-title>
          <year>2011</year>
          <edition>11th ed</edition>
          <publisher-loc>London, UK</publisher-loc>
          <publisher-name>Saunders/Elsevier</publisher-name>
          <fpage>126</fpage>
        </element-citation>
      </ref>
      <ref id="ref6">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Geria</surname>
              <given-names>AN</given-names>
            </name>
            <name>
              <surname>Tajirian</surname>
              <given-names>AL</given-names>
            </name>
            <name>
              <surname>Kihiczak</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Schwartz</surname>
              <given-names>RA</given-names>
            </name>
          </person-group>
          <article-title>Minocycline-induced skin pigmentation: An update</article-title>
          <source>ActaDermatovenerolCroat</source>
          <year>2009</year>
          <volume>17</volume>
          <fpage>123</fpage>
          <lpage>6</lpage>
        </element-citation>
      </ref>
      <ref id="ref7">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Alster</surname>
              <given-names>TS</given-names>
            </name>
            <name>
              <surname>Gupta</surname>
              <given-names>SN</given-names>
            </name>
          </person-group>
          <article-title>Minocycline-induced hyperpigmentation treated with a 755-nm Q-switched alexandrite laser</article-title>
          <source>DermatolSurg</source>
          <year>2004</year>
          <volume>30</volume>
          <fpage>1201</fpage>
          <lpage>4</lpage>
        </element-citation>
      </ref>
      <ref id="ref8">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Collins</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Cotterill</surname>
              <given-names>JA</given-names>
            </name>
          </person-group>
          <article-title>Minocycline-induced pigmentation resolves after treatment with the Q-switched ruby laser</article-title>
          <source>Br J Dermatol</source>
          <year>1996</year>
          <volume>135</volume>
          <fpage>317</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="pmid">8881684</pub-id>
        </element-citation>
      </ref>
      <ref id="ref9">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Eedy</surname>
              <given-names>DJ</given-names>
            </name>
            <name>
              <surname>Burrows</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>Minocycline-induced pigmentation occurring in two sisters</article-title>
          <source>ClinExpDermatol</source>
          <year>1991</year>
          <volume>16</volume>
          <fpage>55</fpage>
          <lpage>7</lpage>
        </element-citation>
      </ref>
      <ref id="ref10">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Layton</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Cunliffe</surname>
              <given-names>WJ</given-names>
            </name>
          </person-group>
          <article-title>Minocycline induced pigmentation in the treatment of acne-a review and personal observations</article-title>
          <source>J Dermatol Treat</source>
          <year>1989</year>
          <volume>1</volume>
          <fpage>9</fpage>
          <lpage>12</lpage>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
